Crossmark

Prognostic value of atherogenic index of plasma on the all-cause and causes-specific mortality among patients with metabolic dysfunction-associated steatotic liver disease

Crossref DOI link: https://doi.org/10.1186/s13098-025-01800-x

Published Online: 2025-06-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Song, Guo

Chu, Heyu

Liu, Yuting

Liu, Xiaoli

Gu, Rong
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (No. 81870291)

Clinical Trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University (2023-LCYJ-PY-34)
License Information

Text and Data Mining valid from 2025-06-14

Version of Record valid from 2025-06-14
More Information

Article History

Received: 12 November 2024

Accepted: 5 June 2025

First Online: 14 June 2025

Declarations

:

: All procedures conducted in studies involving human participants adhered to the ethical standards set forth by the institutional and national research committee, in accordance with the 1964 Helsinki Declaration and its subsequent amendments, or equivalent ethical standards.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below